Literature DB >> 16918502

Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

B Joshi1, S Rastogi, M Morris, L M Carastro, C DeCook, E Seto, S P Chellappan.   

Abstract

Prohibitin is a 30 kDa growth suppressive protein that has pleiotropic functions in the cell. Although prohibitin has been demonstrated to have potent transcriptional regulatory functions, it has also been proposed to facilitate protein folding in the mitochondria and promote cell migration in association with Raf-1. Our previous studies have shown that prohibitin physically interacts with the marked-box domain of E2F family members and represses their transcriptional activity; in contrast, prohibitin could bind to and enhance the transcriptional activity of p53. Here, we show that promoters of human YY1 (Yin and Yang 1) as well as caspase 7 genes are modulated by prohibitin. YY1 promoter activity was reduced upon overexpression of prohibitin, while it was enhanced when prohibitin was depleted by small interfering RNA techniques. The repressive effects of prohibitin on the YY1 promoter were mediated through E2F binding sites, as seen by mutational analysis and chromatin immunoprecipitation assays. Further, depletion of E2F1 prevented prohibitin from repressing the YY1 promoter. In contrast with YY1, prohibitin overexpression led to enhanced levels of caspase 7, whereas depletion of prohibitin reduced it. Interestingly, the caspase 7 promoter was found to have p53-binding sites and prohibitin activated this promoter through p53. These studies show that prohibitin can have diverse effects on the expression of different genes and the activity of various cellular promoters is affected by prohibitin. Further, it appears very likely that prohibitin carries out many of its cellular functions by affecting the transcription of different genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16918502      PMCID: PMC1698671          DOI: 10.1042/BJ20060364

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Mechanisms of caspase activation.

Authors:  Kelly M Boatright; Guy S Salvesen
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

2.  Differential regulation of E2F1 apoptotic target genes in response to DNA damage.

Authors:  Natalia Pediconi; Alessandra Ianari; Antonio Costanzo; Laura Belloni; Rita Gallo; Letizia Cimino; Antonio Porcellini; Isabella Screpanti; Clara Balsano; Edoardo Alesse; Alberto Gulino; Massimo Levrero
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

3.  Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch.

Authors:  Tien-Shun Yeh; Yu-Min Lin; Rong-Hong Hsieh; Min-Jen Tseng
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

4.  BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.

Authors:  Sheng Wang; Baohua Zhang; Douglas V Faller
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

Review 5.  Cell immortality and hallmarks of cancer.

Authors:  Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

6.  Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling.

Authors:  Gina Fusaro; Piyali Dasgupta; Shipra Rastogi; Bharat Joshi; Srikumar Chellappan
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

7.  Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.

Authors:  Luguo Sun; Lanying Liu; Xiang-Jiao Yang; Zhenguo Wu
Journal:  J Cell Sci       Date:  2004-06-01       Impact factor: 5.285

8.  A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis.

Authors:  Bharat Joshi; Danette Ko; Dalia Ordonez-Ercan; Srikumar P Chellappan
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

9.  Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Authors:  Simon C Gamble; Michael Odontiadis; Jonathan Waxman; Jules A Westbrook; Michael J Dunn; Robin Wait; Eric W-F Lam; Charlotte L Bevan
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

10.  Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells.

Authors:  M J Nuell; D A Stewart; L Walker; V Friedman; C M Wood; G A Owens; J R Smith; E L Schneider; R Dell' Orco; C K Lumpkin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

View more
  26 in total

1.  Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Authors:  Arianne L Theiss; Hamed Laroui; Tracy S Obertone; Indrajit Chowdhury; Winston E Thompson; Didier Merlin; Shanthi V Sitaraman
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

2.  Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.

Authors:  Dhiraj Sikaria; Yaping N Tu; Diana A Fisler; James A Mauro; George Blanck
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

3.  Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.

Authors:  Stephen Mallon; Bassam T Wakim; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 4.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

Review 5.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

6.  MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.

Authors:  Shan-Zhong Yang; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

7.  Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.

Authors:  Mohammad Zeeshan Najm; Shuaib Zaidi; Waseem Ahmad Siddiqui; Syed Akhtar Husain
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

8.  Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.

Authors:  Arianne L Theiss; Aaron K Jenkins; Ngozi I Okoro; Jan-Michael A Klapproth; Didier Merlin; Shanthi V Sitaraman
Journal:  Mol Biol Cell       Date:  2009-08-26       Impact factor: 4.138

9.  Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells.

Authors:  Dong-Hui Xu; Jian Tang; Qi-Fu Li; Song-Lin Shi; Xiang-Feng Chen; Ying Liang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

10.  Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1.

Authors:  Tomás Racek; Sven Buhlmann; Franziska Rüst; Susanne Knoll; Vijay Alla; Brigitte M Pützer
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.